Upcoming MRNA earnings date and every past earnings report, with free AI analysis of each 10-K and 10-Q straight from SEC EDGAR filings.
November 4, 2026before market open
Moderna is scheduled to report earnings on this date according to earnings-calendar data from Finnhub and Financial Modeling Prep. Dates can change until the company officially confirms them.
Moderna (MRNA) reported Q2 FY2026 revenue of $145M (+2.1% YoY) and narrowed its net loss to -$782M, supported by a 21.8% decline in cost of revenue and lower…
Moderna reported Q1 FY2026 revenue of $389M (+260.2% YoY) driven by product sales recovery, but posted a net loss of -$1.34B as cost of revenue surged 961% and…
Moderna reported FY2025 revenue of $1.94B, down 39.9% year-over-year, with a net loss of $2.82B as the company continues heavy investment in its pipeline amid…
Moderna (MRNA) is scheduled to report earnings on November 4, 2026, before market open, according to Finnhub's earnings calendar. Dates can change until the company officially confirms them.
Moderna's most recent earnings report was its Q2 FY2026 10-Q, filed with the SEC on July 31, 2026.
EarningsLens publishes free AI analysis of every MRNA 10-K and 10-Q filing. The latest covers Q2 FY2026 — open it from the report history on this page.
Like all U.S.-listed public companies, Moderna reports four times a year: three quarterly 10-Q filings and one annual 10-K filing with the SEC.